Janux Therapeutics Q3 EPS $(0.34) Beats $(0.46) Estimate, Sales $9.290M Beat $7.746M Estimate
Benzinga Newsdesk 57 minutes ago
NewsEarningsEarnings Beats
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.46) by 26.09 percent. This is a 12.82 percent increase over losses of $(0.39) per share
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.46) by 26.09 percent. This is a 12.82 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $9.290 million which beat the analyst consensus estimate of $7.746 million by 19.93 percent. This is a 7.10 percent decrease over sales of $10.000 million the same period last year.